Metagenomi Therapeutics (MGX) Current Taxes (2023 - 2024)
Metagenomi Therapeutics (MGX) reported Current Taxes of $3.3 million for Q1 2024, little changed quarter-over-quarter from $3.3 million in Q4 2023.
Metagenomi Therapeutics (MGX) Current Taxes (2023 - 2024) Analysis & Trends
Metagenomi Therapeutics (MGX) has 2 years of Current Taxes data on file, last reported at $3.3 million in Q1 2024.
- Current Taxes for Q1 2024 came in at $3.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $3.3 million (changed N/A YoY), and the FY2023 annual result was $3.3 million, changed N/A from the prior year.
- Current Taxes steadied at $3.3 million in Q1 2024 per MGX's latest filing, from $3.3 million in the prior quarter.
- Over five years, Current Taxes peaked at $3.3 million in Q4 2023 and troughed at $3.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | 10,460.56 |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 3.27 Mn |